N04.2 Nephrotic syndrome with diffuse membranous glomerulonephritis

Name of the Condition

• Nephrotic Syndrome with Diffuse Membranous Glomerulonephritis
• ICD-10 Code: N04.2

Summary

Nephrotic syndrome with diffuse membranous glomerulonephritis is a kidney disorder characterized by the classic nephrotic syndrome triad—significant proteinuria, hypoalbuminemia, and edema—along with elevated cholesterol levels. The "diffuse membranous glomerulonephritis" refers to specific structural changes in the kidney's filtering units (glomeruli), where immune deposits form along the glomerular basement membrane, impairing filtration.

Causes

The condition often arises from primary kidney diseases, such as idiopathic membranous nephropathy, where the immune system mistakenly targets the glomeruli. Secondary causes may include infections (e.g., hepatitis B/C), autoimmune diseases (e.g., lupus), or medications, though the exact etiology is sometimes unclear.

Risk Factors

• Genetic predisposition to kidney disease
• Underlying conditions like diabetes or autoimmune disorders
• Exposure to certain drugs (e.g., NSAIDs)
• Recent infections (e.g., hepatitis B/C, HIV)

Symptoms

• Severe swelling (edema) in the legs, ankles, or around the eyes
• Foamy or frothy urine due to excess protein
• Unexplained weight gain from fluid retention
• Fatigue and loss of appetite

Diagnosis

Diagnosis involves urine tests to detect proteinuria, blood tests to assess kidney function and albumin levels, and a kidney biopsy to confirm the presence of diffuse membranous glomerulonephritis. Imaging or additional tests may be used to rule out secondary causes.

Treatment Options

• Corticosteroids or other immunosuppressants to reduce inflammation
• Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) to manage proteinuria and blood pressure
• Diuretics to reduce edema
• Cholesterol-lowering medications (e.g., statins) to address hyperlipidemia

Prognosis and Follow-Up

Prognosis varies depending on the underlying cause and response to treatment. Some patients achieve remission, while others may experience progressive kidney damage. Regular follow-up with kidney function tests and blood pressure monitoring is essential to detect complications early.

Complications

• Chronic kidney disease or kidney failure
• Blood clots (thromboembolism) due to increased protein loss
• Infections from immunosuppressive therapy
• Malnutrition or vitamin deficiencies from protein loss

Lifestyle & Prevention

• Limit salt intake to reduce edema
• Maintain a balanced diet with adequate protein and low cholesterol
• Stay hydrated and avoid nephrotoxic medications (e.g., NSAIDs)
• Manage underlying conditions like diabetes or hypertension

When to Seek Professional Help

Seek immediate medical attention for:

• Sudden severe swelling or difficulty breathing
• Blood in urine or decreased urine output
• Unexplained weight gain or persistent fatigue
• Signs of infection (e.g., fever, chills)

Tips for Medical Coders

When coding N04.2, ensure documentation specifies "diffuse membranous glomerulonephritis" to confirm the morphologic changes. Verify that nephrotic syndrome criteria (proteinuria, hypoalbuminemia, edema) are present. If secondary causes (e.g., infections, autoimmune diseases) are documented, consider additional codes as appropriate.